Craig Gilgallon
Oprichter bij Cingulate Works, Inc.
Vermogen: 6 830 $ op 31-05-2024
Actieve functies van Craig Gilgallon
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Cingulate Works, Inc.
 Cingulate Works, Inc. Pharmaceuticals: MajorHealth Technology Cingulate Works, Inc. is a clinical stage biopharmaceutical company which operates drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products. Its products designed to improve the lives of patients suffering from burdensome daily dosing regimens and suboptimal treatment outcomes. The company was founded by Shane J. Schaffer, Matthew N. Brams, Raul R. Silva & Craig Steven Gilgallon in 2013 and is headquartered in Kansas City, KS. | Algemeen Adviseur | 01-01-2013 | - |
| Oprichter | 01-01-2013 | - | |
| Bedrijfssecretaris | 01-01-2013 | - | |
| Operationeel Directeur | 01-03-2017 | 01-11-2017 | |
| Pawar Gilgallon & Rudy LLC | Corporate Officer/Principal | 01-01-2012 | - |
Loopbaan van Craig Gilgallon
Eerdere bekende functies van Craig Gilgallon
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Cingulate Therapeutics LLC
 Cingulate Therapeutics LLC Pharmaceuticals: MajorHealth Technology Cingulate Therapeutics LLC operates as a biopharmaceutical company. It focuses on the development of new products for the treatment of central nervous system and neurobiological disorders. The company was founded by Shane J. Schaffer, Patrick Joseph Gallagher, Matthew Brams, Arthur B. Sthraughn, Craig S. Gilgallon and Raul R. Silva and is headquartered in Kansas City, KS. | Compliance Officer | 01-01-2012 | 15-12-2023 |
| Oprichter | - | 15-12-2023 | |
| Algemeen Adviseur | 01-11-2012 | 15-12-2023 | |
| CINGULATE INC. | Oprichter | 01-01-2013 | 15-12-2023 |
| Algemeen Adviseur | 01-01-2013 | 15-12-2023 | |
| Bedrijfssecretaris | 01-01-2013 | 15-12-2023 |
Opleiding van Craig Gilgallon
| Thomas Jefferson School of Law | Graduate Degree |
| Ithaca College | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 7 |
Operationeel
| Founder | 3 |
| General Counsel | 3 |
| Corporate Secretary | 2 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CINGULATE INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Cingulate Therapeutics LLC
Cingulate Therapeutics LLC Pharmaceuticals: MajorHealth Technology Cingulate Therapeutics LLC operates as a biopharmaceutical company. It focuses on the development of new products for the treatment of central nervous system and neurobiological disorders. The company was founded by Shane J. Schaffer, Patrick Joseph Gallagher, Matthew Brams, Arthur B. Sthraughn, Craig S. Gilgallon and Raul R. Silva and is headquartered in Kansas City, KS. | Health Technology |
Cingulate Works, Inc.
Cingulate Works, Inc. Pharmaceuticals: MajorHealth Technology Cingulate Works, Inc. is a clinical stage biopharmaceutical company which operates drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products. Its products designed to improve the lives of patients suffering from burdensome daily dosing regimens and suboptimal treatment outcomes. The company was founded by Shane J. Schaffer, Matthew N. Brams, Raul R. Silva & Craig Steven Gilgallon in 2013 and is headquartered in Kansas City, KS. | Health Technology |
| Pawar Gilgallon & Rudy LLC |
- Beurs
- Insiders
- Craig Gilgallon
- Ervaring
